title: Surgical treatment of cranial arteriovenous malformations and dural arteriovenous fistulas.
abstract: Microsurgical resection remains the treatment of choice for more than half of all patients with arteriovenous malformations (AVMs). It reduces the treatment window to a span of a few weeks and is curative. Careful patient selection, meticulous surgical planning, and painstaking technical execution of surgery are typically rewarded with excellent outcomes. For dural arteriovenous fistulas (DAVFs), microsurgical obliteration is often reserved for cases in which endovascular therapy either cannot be pursued or fails. When performed, however, microsurgical obliteration of DAVFs is associated with excellent outcomes as well. This article reviews the current state of microsurgical treatment of AVMs and DAVFs.
authors: Division of Cerebrovascular Neurosurgery, Department of Neurosurgery, The Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287, USA.
authors: Gustavo
authors: G
authors: Pradilla
authors: Alexander L
authors: AL
authors: Coon
authors: Judy
authors: J
authors: Huang
authors: Rafael J
authors: RJ
authors: Tamargo
mesh_terms: D001164:Arteriovenous Fistula / Q000000981:diagnostic imaging / Q000601:surgery*; D020785:Central Nervous System Vascular Malformations / Q000000981:diagnostic imaging / Q000601:surgery*; D002533:Cerebral Angiography; D004621:Embolization, Therapeutic; D006801:Humans; D002538:Intracranial Arteriovenous Malformations / Q000000981:diagnostic imaging / Q000601:surgery*; D018810:Magnetic Resonance Angiography; D008279:Magnetic Resonance Imaging; D019635:Neurosurgical Procedures / Q000009:adverse effects / Q000379:methods*; D018579:Patient Selection; D012307:Risk Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome